11. CTNI-08. DB102-01 ENGAGE STUDY: A BIOMARKER-GUIDED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER PHASE 3 CLINICAL TRIAL OF DB102 IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM). (12th November 2021) Authors: Bota, Daniela; Butowski, Nicholas; Piccioni, David; De la Fuente, Macarena; Mao, Ying; Li, Wen-Bin; Trusheim, John; Fink, Karen; Campian, Jian; Lobbous, Mina; Portnow, Jana; Zhu, Jay-Jiguang; Pearlman, Michael; Rudnick, Jeremy; Lesser, Glen; Drappatz, Jan; Vaillant, Brian; Sun, Show-Li; Luo, Wen Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. CTNI-53. RADIATION TREATMENT VOLUMES BEFORE AND AFTER BRAF/MEK THERAPY IN NEWLY DIAGNOSED PAPILLARY CRANIOPHARYNGIOMAS: A CORRELATIVE ANALYSIS OF THE ALLIANCE A071601 PHASE II TRIAL. (12th November 2021) Authors: Shih, Helen; Tabrizi, Shervin; Kabat, Brian; Twohy, Erin; Geyer, Susan; Vora, Shivangi; Gerstner, Elizabeth; Kaufmann, Timothy; Ruff, Michael; Reardon, David; Cohen, Adam; Bota, Daniela; Agarwalla, Pankaj; De la Fuente, Macarena; Lesser, Glen; Campian, Jian; Kumthekar, Priya; Knopp, Michael; Cahi... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. DDRE-22. NOVEL LonP1 INHIBITORS FOR TARGETING GLIOMA STEM CELLS. (9th November 2020) Authors: Douglas, Christopher; Di, Kaijun; Lomeli, Naomi; Bota, Daniela Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. DDRE-31. MITOCHONDRIAL TRAFFICKING AS A TARGET FOR GBM THERAPY. (12th November 2021) Authors: Lepe, Javier; Douglas, Christopher; Lomeli, Naomi; Di, Kaijun; Das, Bhaskar; Bota, Daniela Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. DDRE-38. MAGMAS INHIBITION IN MEDULLOBLASTOMA CELL CULTURES AND PATIENT-DERIVED XENOGRAFT MODELS: POTENTIAL THERAPEUTIC IMPLICATIONS. (12th November 2021) Authors: Hoerig, Clay; Plant-Fox, Ashley; Lepe, Javier; Douglas, Christopher; Lomeli, Naomi; Di, Kaijun; Das, Bhaskar; Bota, Daniela Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. DDRE-50. INVESTIGATING THE ROLE OF LonP1 IN GLIOBLASTOMA TUMOR PROGRESSION. (12th November 2021) Authors: Douglas, Christopher; Bota, Daniela; Di, Kaijun; Das, Bhaskar; Lepe, Javier Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. EXTH-19. EVALUATING THE ANTI-TUMOR EFFECT OF A NOVEL THERAPEUTIC AGENT, MAGMAS INHIBITOR, IN MALIGNANT GLIOMA. (9th November 2020) Authors: Di, Kaijun; Du, Senjie; Lepe, Javier; Nandwana, Nitesh; Das, Bhaskar; Bota, Daniela Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. EXTH-50. IDENTIFYING TRIM11 AS A POTENTIAL THERAPEUTIC TARGET FOR MALIGNANT GLIOMAS. (14th November 2022) Authors: Di, Kaijun; Abrams, Daniela; Yadav, Pratik; Das, Bhaskar; Bota, Daniela Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. IMMU-27. LONG TERM STABILIZATION OF RECURRENT HIGH-GRADE GLIOMA WITH PD-1 INHIBITOR PEMBROLIZUMAB IN TWO CASES. (12th November 2021) Authors: Moldenhauer, Matthew; Du, Steven; Fu, Dan; Myung, Joon; Bota, Daniela; Kong, Xiao-Tang Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. INNV-18. PROLONGED REMISSION AFTER TREATMENT WITH SINGLE-AGENT IBRUTINIB AS MAINTENANCE THERAPY FOLLOWING SALVAGE RADIATION THERAPY FOR REFRACTORY/RELAPSE PRIMARY CNS LYMPHOMA. (14th November 2022) Authors: Du, Steven; Bota, Daniela; Kong, Xiao-Tang Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗